Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-quality Linac-based Stereotactic Body Radiation Therapy with Flattening Filter Free Beams and Volumetric Modulated Arc Therapy for Low-Intermediate Risk Prostate Cancer. A Mono-institutional Experience with 90 Patients.
D'Agostino G, Franzese C, De Rose F, Franceschini D, Comito T, Villa E, Alongi F, Liardo R, Tomatis S, Navarria P, Mancosu P, Reggiori G, Cozzi L, Scorsetti M. D'Agostino G, et al. Among authors: franceschini d. Clin Oncol (R Coll Radiol). 2016 Dec;28(12):e173-e178. doi: 10.1016/j.clon.2016.06.013. Epub 2016 Jul 4. Clin Oncol (R Coll Radiol). 2016. PMID: 27389021 Clinical Trial.
Stereotactic radiotherapy for isolated nodal recurrence of prostate cancer.
Detti B, Bonomo P, Masi L, Doro R, Cipressi S, Iermano C, Bonucci I, Franceschini D, Di Brina L, Bakhi M, Simontacchi G, Meattini I, Livi L. Detti B, et al. Among authors: franceschini d. World J Urol. 2015 Aug;33(8):1197-203. doi: 10.1007/s00345-014-1427-x. Epub 2014 Oct 24. World J Urol. 2015. PMID: 25342516
Cyberknife treatment for low and intermediate risk prostate cancer.
Detti B, Bonomo P, Masi L, Doro R, Cipressi S, Iermano C, Bonucci I, Franceschini D, Di Cataldo V, Di Brina L, Baki M, Simontacchi G, Meattini I, Carini M, Serni S, Nicita G, Livi L. Detti B, et al. Among authors: franceschini d. Cancer Invest. 2015 May;33(5):188-92. doi: 10.3109/07357907.2015.1019679. Epub 2015 Apr 1. Cancer Invest. 2015. PMID: 25831274
Toxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy.
Franzese C, Fogliata A, Clerici E, Franceschini D, Villa E, D'Agostino G, Navarria P, Mancosu P, Tomatis S, Cozzi L, Scorsetti M. Franzese C, et al. Among authors: d agostino g, franceschini d. Radiat Oncol. 2015 Nov 6;10:224. doi: 10.1186/s13014-015-0535-0. Radiat Oncol. 2015. PMID: 26545871 Free PMC article.
Hypo-fractionated stereotactic radiotherapy alone using volumetric modulated arc therapy for patients with single, large brain metastases unsuitable for surgical resection.
Navarria P, Pessina F, Cozzi L, Ascolese AM, De Rose F, Fogliata A, Franzese C, Franceschini D, Tozzi A, D'Agostino G, Comito T, Iftode C, Maggi G, Reggiori G, Bello L, Scorsetti M. Navarria P, et al. Among authors: d agostino g, franceschini d. Radiat Oncol. 2016 Jun 2;11:76. doi: 10.1186/s13014-016-0653-3. Radiat Oncol. 2016. PMID: 27249940 Free PMC article.
Can Stereotactic Body Radiation Therapy Be a Viable and Efficient Therapeutic Option for Unresectable Locally Advanced Pancreatic Adenocarcinoma? Results of a Phase 2 Study.
Comito T, Cozzi L, Clerici E, Franzese C, Tozzi A, Iftode C, Navarria P, D'Agostino G, Rimassa L, Carnaghi C, Personeni N, Tronconi MC, De Rose F, Franceschini D, Ascolese AM, Fogliata A, Tomatis S, Santoro A, Zerbi A, Scorsetti M. Comito T, et al. Among authors: d agostino g, franceschini d. Technol Cancer Res Treat. 2017 Jun;16(3):295-301. doi: 10.1177/1533034616650778. Epub 2016 Jun 16. Technol Cancer Res Treat. 2017. PMID: 27311310 Free PMC article. Clinical Trial.
236 results